Bull of the Day: F5 Networks (FFIV)
Earnings momentum looks to take this stock to all-time highs and beyond.
F5 Networks (FFIV) is a Zacks Rank #1 (Strong Buy) that provides multi-cloud application services for the security, performance, and availability of network applications, servers, and storage systems.
The stock has been trading sideways all year, but after an earnings beat, estimates are headed higher. Bulls are now looking for a run to all-time highs and a breakout into the end of the year.
About the Company
F5 Networks focus is multi-cloud applications that enable customers to address performance, security, automation and insight. The company caters to banking & financial services, federal government Agencies, and service providers. F5 also provides a range of professional services, including consulting, training, installation, maintenance, and other technical support services.
The company has over 6,000 full time employees and is headquartered in Seattle, Washington. Founded in 1996, F5 has partnerships with large cloud providers such as Amazon Web Services, Microsoft Azure, and Google Cloud Platform.
F5 Networks has a market cap of $12 Billion and has Zacks Style Scores of “F” in Growth and “D” in Value. The stock has a Forward PE is 20 and pays no dividend.
F5 reported back in July, seeing a 12% beat on EPS. Revenues came in above expectations at $652 million v the $637 million expected. The company guided EPS in a range above expectations, now looking for Q4 at $2.68-2.80 v the $2.73 expected.
Management commented that “Customers’ traditional applications are generating more revenue and more engagement than ever before”. They added that customers “are accelerating adoption of modern application architectures, like Kubernetes, for new applications”.
The beat was the company’s eight straight and since that streak has begun, the stock is up over 40%.
F5 Networks, Inc. Price and EPS Surprise
Over the last 30 days, estimates have turned higher. For the current year, we have seen estimate raised from $10.54 to $10.61. For next year, we see estimates at $11.87, up from $11.79.
In addition to estimates, some analysts have taken their price targets higher since earnings. JPMorgan Chase has FFIV at Overweight and a $230 price target and MKM Partners has the stock at a Buy and $248 target.
Firms are citing strong software growth expectations in 2022 as the reason to be bullish into next year.
The stock is above most moving averages, with the 50-day recently holding at $196. The 200-day is at $190, which is further away than all-time highs at $216.15.
A couple Fibonacci setups on the charts with a smaller one drawn from the April highs to recent lows. The 161.8% extensions are $237, about 15% from current levels.
If we draw from 2018 highs to the COVID crash lows, we get an 161.8% extension target of $275. This would be a move of about 35% higher from today’s levels.
F5 has struggled all year, but after the recent earnings some momentum has come back into the name. Strong software growth is expected, so watch for the company to continue to beat numbers.
On the technical front, the stock looks ready to breakout. However, it will likely need a positive catalyst to get to those price targets mentioned above.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
F5 Networks, Inc. (FFIV): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research